CLOs on the Move

Portola

www.portola.com

 
Portola Pharmaceuticals is dedicated to developing and commercializing therapies that transform patient lives and advance patient care by changing treatment paradigms in thrombosis and other hematologic diseases. Our two lead assets are Bevyxxa® (betrixaban), and andexanet alfa. In addition, cerdulatinib is our investigational Syk/JAK inhibitor to treat hematologic cancers. These compounds come from our own internal research efforts and represent important advances to address significant unmet needs. We are employing novel strategies that may increase the likelihood of clinical, regulatory and commercial success of our potentially lifesaving therapies.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.portola.com
  • 270 E. Grand Avenue
    South San Francisco, CA USA 94080
  • Phone: 650.246.7000

Executives

Name Title Contact Details
Michael Ouimette
Vice President and Assistant Secretary, Legal Profile
Michael Ouimette
Executive Director and Assistant Corporate Secretary Profile
John Moriarty
Executive Vice President and General Counsel Profile
John Moriarty
Executive Vice President, General Counsel and Secretary Profile

Similar Companies

Va Urology Ctr

Va Urology Ctr is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in Henrico, VA. To find more information about Va Urology Ctr, please visit www.uro.com

Essential HealthCare Solutions

Essential HealthCare Solutions is a Layton, UT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Greene Health Partners

Greene Health Partners is one of the leading companies in Healthcare, Pharmaceuticals, & Biotech industry. Greene Health Partners is based in Xenia, OH. You can find more information on Greene Health Partners at www.greenehealth.org

Dauterman Medical

Dauterman Medical is a Aiea, HI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

HMA Inc

HMA Inc is a Tempe, AZ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.